National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser

Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial, nanotechnology and scientific markets, today announced that the National Cancer Institute, a division of the U.S. National Institute of Health (NIH) has released positive test results conducted on Zecotek's proprietary Tunable Green Fiber Laser.

Dr. William Telford, the Director of the National Cancer Institute Flow Cytometry Core Laboratory in Bethesda MD, reported that Zecotek's Tunable Green Fiber Laser provides both lower noise and enhanced detection resolution over the entire tunable range of 540nm to 550nm, resulting in an improvement in data collection and an increase in analytical capability.

“The test results from the National Cancer Institute show that Zecotek's Tunable Green Fiber Laser performs better than alternative lasers in an area of research that directly contributes to the advancement of bio-instrumentation,” said Dr. A.F. Zerrouk, Chairman, President and CEO of Zecotek. “Dr. Telford is a highly respected scientist and his research is closely followed by industry as well as other leading researchers. His observations on the advantages of our Tunable Green Fiber Lasers for flow cytometry fully support the commitment and efforts we have made to bring this important technology to market.”

Dr. Telford presented the test results at the prestigious Congress for the International Advancement of Cytometry (CYTO), held in Seattle in early May and attended by leading researchers, practitioners and bio-instrumentation manufacturers. He noted that both Zecotek's tunable and fixed wavelength Green Fiber Lasers are ideal for utilizing the many new fluorescent probes for various applications, including fundamental research in immunology, hematology, organ transplantation and other biomedical fields. Dr. Telford also noted that tunable lasers will now make virtually any fluorochrome accessible to analysis and importantly will also provide for new types of flourochromes not presently available to research. According to Dr. Telford, tuneability “will become a future requirement by end users and the research community.”

Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zecotek Photonics. (2019, February 13). National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser. AZoNano. Retrieved on March 02, 2024 from https://www.azonano.com/news.aspx?newsID=18371.

  • MLA

    Zecotek Photonics. "National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser". AZoNano. 02 March 2024. <https://www.azonano.com/news.aspx?newsID=18371>.

  • Chicago

    Zecotek Photonics. "National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser". AZoNano. https://www.azonano.com/news.aspx?newsID=18371. (accessed March 02, 2024).

  • Harvard

    Zecotek Photonics. 2019. National Cancer Institute Announces Successful Test Results of Zecotek's Tunable Green Fiber Laser. AZoNano, viewed 02 March 2024, https://www.azonano.com/news.aspx?newsID=18371.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.